Anticancer drugs: second malignancies--risk reduction.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000633:toxicity*; D003520:Cyclophosphamide / Q000633:toxicity; D005260:Female; D005472:Fluorouracil / Q000633:toxicity; D008297:Male; D015080:Mesna / Q000031:analogs & derivatives / Q000627:therapeutic use; D008727:Methotrexate / Q000633:toxicity; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced* / Q000517:prevention & control; D051381:Rats; D014750:Vincristine / Q000633:toxicity
D014750:Vincristine; C027032:2,2'-dithiodiethanesulfonic acid; D003520:Cyclophosphamide; D015080:Mesna; D005472:Fluorouracil; D008727:Methotrexate